Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Expenses (Tables)

Accounts Payable and Accrued Expenses (Tables)

6 Months Ended

Jun. 30, 2022

Accrued Liabilities and other Long-Term Liabilities [Abstract]

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following:




		June 30,				December 31,
($ in thousands)		2022			2021

Accounts Payable		$	53,939		$	47,429
Accrued expenses:
Professional fees			1,796			1,835
Salaries, bonus and related benefits			7,510			8,809
Research and development			8,736			7,932
Research and development - license maintenance fees			502			4,640
Research and development - milestones			4,600			850
Accrued royalties payable			3,027			3,833
Accrued coupon and rebates			8,205			10,603
Return reserve			2,727			3,240
Accrued interest			204			—
Other			2,294			1,489
Total accounts payable and accrued expenses		$	93,540		$	90,660